Molsid company

Prof. Rafael Cantóns research activity is developed within the Spanish Network for Research in Infectious Diseases (CIBERINFEC, https://www.ciberinfec.es/) and Institute Ramón y Cajal for Health Research (IRYCIS, http://www.irycis.org) in which he coordinates the Microbiology, Immunology and Infection Area. This activity is focussed on antimicrobial resistance mechanisms, including extended-spectrum beta-lactamases and carbapenemases, antimicrobial susceptibility testing, respiratory tract infections (mainly in bronchiectasis and cystic fibrosis), and interplay of clonal epidemiology and resistance. He is currently the clinical data coordinator of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) (former president). He has been President of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). He has published more than 600 articles in peer-review journals, 55 book chapters and had several communications on international meeting and congresses. His H factor is 96. He is member of the editorial board of Microbial Drug Resistant, Drug Resistance Updates, Diagnostic Microbiology and Infectious Diseases, Enfermedades Infecciosas y Microbiología Clinica and Revista Española de Quimioterapia journals. He is editor of the Clinical Microbiology Procedures of the SEIMC (https://seimc.org/).

Beverly Egyir activities comprise research on AMR, participation in the antimicrobial stewardship, and monitoring of hospital and community-acquired infections. She uses state-of-the-art phenotypic and molecular tools to understand the epidemiology of antimicrobial-resistant bacteria isolated from humans, livestock, and the environment. Specifically, she studies superbugs like methicillin-resistant Staphylococcus aureus (MRSA), ESBL-producing bacteria, and others- with an overall goal of tackling antimicrobial resistance in Ghana and on the African continent. She also teaches and supervises undergraduate and postgraduate students in the field of bacteriology and antimicrobial resistance. She has organized several training sessions for students/ laboratory staff on correct identification and performance of standard antimicrobial susceptibility testing of bacterial species. She founded Women in Biomedicine, Africa, an organization born out of a passion to provide mentorship and career guidance for young women in biomedical careers; to harness their skills to significantly improve health care in Africa. She is a member of the National Antimicrobial Resistance Group in Ghana.

David Jenkins has served as lead infection prevention doctor at University Hospitals of Leicester for over 20 years. He is also his Trust’s lead doctor for antimicrobial stewardship. In addition, Dr Jenkins is responsible for undergraduate and postgraduate teaching in infection at the University of Leicester Medical School. He is engaged in research in antimicrobial stewardship and was a co-investigator on an antibiotic prescribing behaviour research project funded by the Economics and Social Research Council, looking at prescribing practice in the UK, South Africa and Sri Lanka. He also took part in a study investigating antimicrobial use and resistance in Cape Verde.

Prof. Frédéric LAURENT is Professor of Microbiology at the Faculty of Pharmacy of Lyon within the University Claude Bernard Lyon 1. He leads the Department for bacteriology within of the Hospices Civils de Lyon (HCL). Frédéric holds a diploma in Medical Biology and obtained his pharmacy thesis in 1997, a PhD in 2000 and an authorization to supervise research (HDR) in 2005. He completed a post-doctoral fellowship at St George’s Hospital-University of London devoted to the The use of genetic approaches (DNA chips) to understand the pathophysiology of staphylococcal infections. He is co-principal investigator of the “Pathogenesis of staphylococcal infections” team within the International Center for Research in Infectiology INSERM U1111-CNRS UMR5308, University Lyon 1, ENS de Lyon and in charge of a dedicated research axis specifically for understanding the pathophysiology of staphylococcal osteoarticular infections.

He is also co-director of the National Reference Center for Staphylococci, which is the pathogen most frequently involved in osteoarticular infections. He has published more than 200 publications since 1995 as well as numerous book chapters. He is a member of the executive committee of the European Staphylococcal Study Groups (EGES) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Robin Patel, M.D., is the director of the Infectious Diseases Research Laboratory. In the research laboratory, she and her colleagues focus on biofilms. Biofilms cause a large number of infections in modern clinical practice, such as prosthetic joint infection and endocarditis.

Prof. Patel is also the chair of the Division of Clinical Microbiology and the director of its Bacteriology Laboratory. In this state-of-the-art clinical facility, she and her colleagues develop and deploy cutting-edge assays for clinical detection of bacteria, identification of bacteria, and characterization of antimicrobial resistance and susceptibility.

Prof. Laurent Poirel is Associate Professor at the Emerging Resistance to Antibiotics Research Unit and Swiss National Reference Center for Emerging Antibiotic Resistance at the University of Fribourg. His research interests emerging mechanisms of resistance to ß-lactams, polymyxins, and quinolones in Gram-negative rods, either in human and veterinary medicine. He is specialized on the genetics of acquisition of resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii, plasmid-mediated quinolone resistance, and polymyxin resistance determinants in Enterobacteriaceae. He has co-invented a series of rapid diagnostic tests for detection of emerging resistance traits. He is the author of ca. 600 publications in international journals, his H-index being 136. He is the Editor-in-Chief of the European Journal of Clinical Microbiology and Infectious Diseases and Associate Editor of two highly-ranked journals, i.e. Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Agents. He has been active member of the ESCMID, being a member of the Executive Subcommittee (2015-2018), co-director of two ESCMID Summer Schools (Borstel 2017 and Paris 2018), and currently member of the ESGARS Executive Committee.

Dr. Mandy Wotton has >20 years of experience in susceptibility testing methods and resistance mechanisms. She is secretary of the BSAC susceptibility testing committee, providing educational workshops and conferences and she is an active participant in developing EUCAST methodology and guidelines for the European Development Laboratory (EDL). Prior to her Cardiff position, she spent over 10 years in clinical research on antibiotics in Bristol, where she completed her PhD in glycopeptide resistance in S. aureus.